11-49158015-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_004476.3(FOLH1):c.1469G>A(p.Gly490Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000188 in 1,593,994 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_004476.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
FOLH1 | NM_004476.3 | c.1469G>A | p.Gly490Asp | missense_variant | 14/19 | ENST00000256999.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
FOLH1 | ENST00000256999.7 | c.1469G>A | p.Gly490Asp | missense_variant | 14/19 | 1 | NM_004476.3 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000592 AC: 9AN: 151906Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000210 AC: 5AN: 237764Hom.: 0 AF XY: 0.0000234 AC XY: 3AN XY: 128476
GnomAD4 exome AF: 0.0000146 AC: 21AN: 1442088Hom.: 0 Cov.: 30 AF XY: 0.0000126 AC XY: 9AN XY: 716102
GnomAD4 genome AF: 0.0000592 AC: 9AN: 151906Hom.: 0 Cov.: 32 AF XY: 0.0000539 AC XY: 4AN XY: 74186
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 02, 2021 | The c.1469G>A (p.G490D) alteration is located in exon 14 (coding exon 14) of the FOLH1 gene. This alteration results from a G to A substitution at nucleotide position 1469, causing the glycine (G) at amino acid position 490 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at